Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial:

Zelie Bailes, MSc Prof Neil Barnes, FRCP Prof Louis-Philippe Boulet, MD Dawn Edwards, MSc Andrew Fowler, BM Nicola A Hanania, MD Prof Huib A M Kerstjens, MD Edward Kerwin, MD Prof Robert Nathan, MD Prof John Oppenheimer, MD Prof Alberto Papi, MD Steven Pascoe, MBBS Prof Guy Brusselle, MD Guy Peachey, BSc Neal Sule, MD Maggie Tabberer, MSc Prof Ian D Pavord, FMedSci

9 September, 2020

NZ Respiratory Research Review Issue 182

Effect of Normobaric Hypoxia on Exercise Performance in Pulmonary Hypertension - Randomized Trial:

Simon R. Schneider, MA Laura C. Mayer, MD Mona Lichtblau, MD Charlotte Berlier, MD Esther I. Schwarz, MD Stéphanie Saxer, MSc Michael Furian, PhD Konrad E. Bloch, Prof. MD Silvia Ulrich, Prof. MD

8 September, 2020

NZ Respiratory Research Review Issue 195

Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI:

Jonathan Cooke, Carl Llor, Rogier Hopstaken, Matthew Dryden, Christopher Butler

6 September, 2020

NZ Respiratory Research Review Issue 196

The most commonly diagnosed and most common causes of cancer death for Māori New Zealanders:

Jason K Gurney, Bridget Robson, Jonathan Koea, Nina Scott, James Stanley, Diana Sarfati

4 September, 2020

NZ Respiratory Research Review Issue 181

Fully weekly antituberculosis regimen: a proof-of-concept study:

Fatma Kort, Laure Fournier Le Ray, Aurélie Chauffour, Vincent Jarlier, Nacer Lounis, Koen Andries, Alexandra Aubry, Lorenzo Guglielmetti, Nicolas Veziris

3 September, 2020

NZ Respiratory Research Review Issue 187

Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study:

Marios Rossides, Susanna Kullberg, Anders Eklund, Daniela Di Giuseppe, Johan Grunewald, Johan Askling, Elizabeth V. Arkema

3 September, 2020

NZ Respiratory Research Review Issue 189

Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study):

Nils Picker, Agnes Y. Lee, Alexander T. Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Lorenzo G. Mantovani, Khaled Abdelgawwad, Samuel Fatoba, Inga-Marion Thate-Waschke, Miriam Bach, Thomas Wilke

2 September, 2020

NZ Respiratory Research Review Issue 190

“I’m Putting My Trust in Their Hands” A Qualitative Study of Patients’ Views on Clinician Initial Communication About Lung Cancer Screening:

Sara E. Golden, MPH, Sarah S. Ono, PHD, Sujata G Thakurta, MPA:HA, Renda Soylemez Wiener, MD, MPH, Jonathan M Iaccarino, MD, Anne C. Melzer, MD, Santanu K. Datta, PhD, MBA, Christopher G. Slatore, MD

1 September, 2020

NZ Respiratory Research Review Issue 181

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension:

Raymond L. Benza, MD Manreet K. Kanwar, MD Amresh Raina, MD Jacqueline V. Scott, MS Carol L. Zhao, MS Mona Selej, MD C. Greg Elliott, MD Harrison W. Farber, MD

31 August, 2020

NZ Respiratory Research Review Issue 183

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma:

Joanne E. Kavanagh, MBChB Andrew P. Hearn, MBBS Jaideep Dhariwal, PhD Gráinne d’Ancona, MSc Abdel Douiri, PhD Cris Roxas, MSc Mariana Fernandes, MSc Linda Green, MSc Louise Thomson, MSc Alexandra M. Nanzer, PhD Brian D. Kent, MD David J. Jackson, PhD

31 August, 2020

NZ Respiratory Research Review Issue 188